quinta-feira, 12 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 16, 2026

Starbucks Corporation Announces Early Results and Upsizing of its Tender Offers for Eight Series of Notes

View original at finance.yahoo.com
“4.500% Senior Notes due 2028 [CUSIP 855244BN8] Aggregate Principal Amount Outstanding: $750,000,000”
Verbatim excerpt from the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Because the aggregate purchase price of tendered Notes exceeds the Aggregate Cap and Maximum Amounts, Starbucks does not expect to accept any further tenders of Notes

    60% confidence
  • Starbucks increased the Aggregate Cap for all Notes to $1.3 billion, the Pool 1 Maximum Amount to $600 million, and the Pool 2 Maximum Amount to $700 million

    60% confidence
  • $2,598,857,000 aggregate principal amount of the Notes were validly tendered prior to or at 5:00 p.m. Eastern Time on May 15, 2026 and not validly withdrawn

    60% confidence
  • The 4.500% Senior Notes due 2048 are subject to an aggregate principal amount sublimit of $200,000,000

    60% confidence
  • Except as described in the May 16 press release, the terms and conditions of the Tender Offers set forth in the Offer to Purchase remain unchanged

    60% confidence

Data points we hold from this source

Starbucks Corporation · principal tendered2598857000 USD
Starbucks Corporation · debt5000000000 USD
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,565 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Starbucks Corporation Announces Early Results and Upsizing of its Tender Offers for Eight Series of Notes — Source | Via News | pt.VIA.NEWS